Ami Fadia
Stock Analyst at Needham
(0)
# 3250
Out of 5,270 analysts
450
Total ratings
38.46%
Success rate
1.48%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Axsome Therapeutics | Reiterates: Buy | 153 153 | 127.09 | 20.39% | 13 | Mar 3, 2025 | |
Avadel Pharmaceutica... | Reiterates: Buy | 19 19 | 7.54 | 151.99% | 33 | Mar 3, 2025 | |
Praxis Precision Med... | Maintains: Buy | 150 85 | 33.79 | 151.55% | 9 | Mar 3, 2025 | |
Merus | Maintains: Buy | 85 83 | 45.61 | 81.98% | 26 | Feb 28, 2025 | |
ACADIA Pharmaceutica... | Reiterates: Buy | 28 28 | 18.14 | 54.36% | 7 | Feb 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 60 59 | 38.31 | 54.01% | 21 | Feb 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 22 | Feb 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 30 30 | 10.5 | 185.71% | 17 | Feb 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 32 32 | 8.26 | 287.41% | 19 | Feb 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 205 210 | 140.19 | 49.8% | 27 | Feb 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 50 50 | 32.21 | 55.23% | 33 | Feb 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 27 | Feb 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 133 133 | 89.66 | 48.34% | 28 | Feb 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 37 | Feb 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 19 | Feb 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 12 | Feb 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 1.48 | 710.81% | 13 | Feb 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 23 23 | 1.42 | 1519.72% | 6 | Jan 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 6 | Jul 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 7 | Mar 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | n/a | n/a | n/a | 1 | Dec 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 40 | n/a | n/a | 1 | Feb 16, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 28 26 | n/a | n/a | 6 | Feb 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 12 16 | 0.51 | 3037.25% | 2 | Feb 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 63 75 | 22.89 | 227.65% | 7 | Jan 21, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 4 5 | n/a | n/a | 2 | Jan 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 10 14 | n/a | n/a | 3 | Oct 2, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 15 23 | 1.32 | 1604.55% | 4 | Oct 1, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 64 63 | 28.89 | 118.07% | 4 | Sep 17, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 2 2 | n/a | n/a | 8 | Sep 14, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 8 10 | n/a | n/a | 2 | Jul 10, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 24 | n/a | n/a | 8 | Jan 27, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 9 20 | n/a | n/a | 2 | Sep 17, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 12 5 | 3.2 | 56.25% | 2 | Jan 30, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Market Perform | n/a | n/a | n/a | 7 | Oct 1, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 12 | n/a | n/a | 5 | Jan 3, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 22 | 2.25 | 877.78% | 4 | Jan 3, 2018 |